Navigation Links
NuvaRing Bellwether Trial Scheduled: Now, AttorneyOne Can Provide Advice
Date:7/31/2013

San Diego, CA (PRWEB) July 31, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on NuvaRing Lawsuit.

According to court documents, the bellwether trial of the first federal NuvaRing lawsuit is scheduled on October 21 (case no 4:2008cv00558, Missouri Eastern District Court). NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. In the lawsuit, the plaintiff claims that she suffered a severe pulmonary embolism from NuvaRing.

On June 7, a federal panel ruled that 5 Nuvaring lawsuits alleging injuries will join the NuvaRing Multidistrict Litigation (MDL No. 1964, U.S. District Court for the Eastern District of Missouri). Court data, updated on July 10, indicate that there are 1,217 actions pending in the NuvaRing MDL. All of the lawsuits concern similar allegations that blood clots from Nuva Ring caused women to suffer injuries including pulmonary embolism, stroke, deep vein thrombosis (DVT) or sudden death.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged NuvaRing severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file NuvaRing lawsuits. "For that reason," he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On April 4, a Williamson County resident filed a lawsuit in Illinois Southern District Court (case no. 3:2013cv00335) alleging his wife suffered pulmonary embolism from her NuvaRing and died.

AttorneyOne.com has further information on NuvaRing lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/7/prweb10972237.htm.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10980977.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NuvaRing Lawsuit Filed by Alonso Krangle on Behalf of a Louisiana Woman Who Developed Pulmonary Embolism Allegedly Due to NuvaRing Use
2. NuvaRing Blood Clot Lawsuit Filed on Behalf of a California Woman Who Developed a Serious Blood Clot Disorder Allegedly Due to Use of NuvaRing, Reports Alonso Krangle
3. NuvaRing Lawsuit News: First New Jersey NuvaRing Trial Scheduled to Start This Week, Rottenstein Law Group LLP Reports
4. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
5. Alleged NuvaRing Blood-Clotting Lawsuits Update: Resource4thePeople Reports Important Hearing Scheduled for July
6. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
7. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
8. NuvaRing Lawsuit News: Rottenstein Law Group Responds to Judge’s Refusal to Dismiss Punitive Damages Claims
9. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
10. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
11. First NuvaRing Lawsuits in State, Federal NuvaRing Litigations Set to Head to Trial Later This Year, Alonso Krangle LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: